FDA conducts March 17 inspection of Masterpiece JP, Inc. in Torrance

Sara Brenner, Principal Deputy Commissioner at FDA
Sara Brenner, Principal Deputy Commissioner at FDA
0Comments

The Food and Drug Administration (FDA) conducted an inspection of Masterpiece JP, Inc. in Torrance on March 17 focused on foodborne biological hazards, according to data posted on the FDA’s website.

The inspection’s final report recommended that Masterpiece JP, Inc. voluntarily address issues related to its management practices.

The FDA carries out routine facility inspections nationwide to confirm that workplaces and their products comply with FDA laws and regulations designed to protect public health. Results from these inspections are released to the public.

According to its website, the FDA is a federal agency overseeing the safety and quality of human and animal drugs, biological products, medical supplies and tobacco products.

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Dr. Mehmet Oz CMS Administrator

Medicaid spending on Temporary National Codes (Non-Medicare) services rises 34.5% in Lomita for 2024

Lomita Medicaid providers collected $1,623,886 for services under the Temporary National Codes (Non-Medicare) group in 2024, a 34.5% increase from the prior year.

Dr. Mehmet Oz CMS Administrator

El Segundo Medicaid payments for Temporary National Codes (Non-Medicare) climb to $8,234,755 in 2024

In 2024, El Segundo Medicaid providers submitted $8,234,755 in claims for Temporary National Codes (Non-Medicare) services, reflecting a 524.8% rise from the prior year.

Dr. Mehmet Oz CMS Administrator

Torrance Medicaid spending for pathology and lab services reached $18,325,656 in 2024

Medicaid providers billed $18,325,656 in Torrance for Pathology and Laboratory Procedures in 2024, representing a 479.2% increase from the prior year.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from South Bay Leader.